Alteration in serum leptin correlates with alterations in serum N-telopeptide of collagen type I and serum osteocalcin during the progression of osteoporosis in ovariectomized rats

Abstract The role of leptin during the progression of osteoporosis was investigated in ovariectomized rats by correlation of serum leptin levels with N-telopeptide of collagen type I (NTx) and osteocalcin levels before ovariectomy and 20, 40 and 60days after the operation. Furthermore, peripheral quantitative computed tomography was used to confirm the development of severe osteoporosis in rats on day 60. The levels of NTx and osteocalcin were significantly increased on day 20 [61.9±5.4nM BCE (bone collagen equivalents) and 215.6±53.3ng/mL, respectively] in comparison to those before ovariectomy (41.3±1.7nM BCE and 60.4±10.9ng/mL). Accordingly, leptin was significantly elevated on day 20 (3033±661 vs. 606±346 pg/mL before ovariectomy). Bone markers and leptin levels remained constant up to day 40, while a slight, but not statistically significant, decrease was noted for osteocalcin and leptin on day 60. Although leptin and bone markers did not correlate before ovariectomy (r=0.09 for NTx and r=−0.05 for osteocalcin), strong correlation was observed at all time points after ovariectomy. The data obtained suggest that the alterations in serum leptin levels during the progression of osteoporosis in ovariectomized rats follow the alterations in bone markers.

[1]  D. C. Bauer,et al.  Clinical Use of Biochemical Markers of Bone Remodeling: Current Status and Future Directions , 2000, Osteoporosis International.

[2]  T. Economopoulos,et al.  Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer. , 2005, Journal of pharmaceutical and biomedical analysis.

[3]  T. Hefferan,et al.  Animal Models For Osteoporosis , 2004, Reviews in Endocrine and Metabolic Disorders.

[4]  J. Auwerx,et al.  Leptin: cutting the fat off the bone , 2003, The Lancet.

[5]  N. Watts,et al.  Clinical utility of biochemical markers of bone remodeling. , 1999, Clinical chemistry.

[6]  R. Moore,et al.  Effects of oophorectomy on biochemical and bone variables in the rat. , 1992, Bone and mineral.

[7]  C. Nappi,et al.  Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. , 2004, Endocrinology.

[8]  G. Lyritis,et al.  Mechanical Stimulation in the Form of Vibration Prevents Postmenopausal Bone Loss in Ovariectomized Rats , 1998, Calcified Tissue International.

[9]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[10]  J. H. Kim,et al.  Can bone turnover markers correlate bone mass at the hip and spine according to menopausal period? , 2000, Archives of Gynecology and Obstetrics.

[11]  C. Drevon,et al.  Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling , 2002, Journal of cellular biochemistry.

[12]  T. Thomas.  The complex effects of leptin on bone metabolism through multiple pathways. , 2004, Current opinion in pharmacology.

[13]  S. Takeda,et al.  A neuro (endo)crine regulation of bone remodeling , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  P Peichl,et al.  Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. , 2001, Clinical biochemistry.

[15]  B. Riggs,et al.  Leptin reduces ovariectomy-induced bone loss in rats. , 2001, Endocrinology.

[16]  N. Karamanos,et al.  Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer. , 2004, Journal of pharmaceutical and biomedical analysis.

[17]  J. Reseland,et al.  Role of leptin in bone growth: central player or peripheral supporter? , 2002, FEBS letters.

[18]  J. Taylor,et al.  Identification of an at risk group for osteoporosis using heel ultrasound measurement in primary care , 1995 .

[19]  C. Vermeer,et al.  Evaluation of a bead-based enzyme immunoassay for the rapid detection of osteocalcin in human serum. , 2000, Clinical chemistry.

[20]  D. Thompson,et al.  FDA Guidelines and animal models for osteoporosis. , 1995, Bone.

[21]  W. Jee,et al.  Overview: animal models of osteopenia and osteoporosis. , 2001, Journal of musculoskeletal & neuronal interactions.

[22]  A. Thorburn,et al.  Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y , 2001, International Journal of Obesity.

[23]  M. Heiman,et al.  Increased weight gain after ovariectomy is not a consequence of leptin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[24]  R. Moore,et al.  Increased bone resorption precedes increased bone formation in the ovariectomized rat , 1996, Calcified Tissue International.

[25]  R H Christenson,et al.  Biochemical markers of bone metabolism: an overview. , 1997, Clinical biochemistry.

[26]  J. Fu,et al.  Simple, Rapid Enzyme-Linked Immunosorbent Assay (ELISA) for the Determination of Rat Osteocalcin , 1999, Calcified Tissue International.

[27]  E. Thompson,et al.  Hormonal regulation of physiological cell turnover and apoptosis , 2000, Cell and Tissue Research.

[28]  F. Casanueva,et al.  Regulation of serum leptin levels by gonadal function in rats. , 1999, European journal of endocrinology.